{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:54:47Z","timestamp":1761562487483,"version":"3.37.3"},"reference-count":23,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"2","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>With the United States in the midst of an opioid overdose epidemic, efforts to reduce overdose deaths have increased. Expanding access to the opioid antagonist naloxone can combat the epidemic. A pilot project in a psychiatric hospital resulted in the development of a screening tool in the electronic medical record (EMR) to help pharmacists identify adult inpatients at high risk of opioid overdose. Pharmacists can facilitate these patients being discharged with take-home naloxone. The purpose of this project was to optimize the screening tool for nonpsychiatric adult inpatient areas. Prior to implementation, a team of pharmacists familiar with the screening tool and take-home naloxone met with stakeholders to assess need for modification of the tool, determine barriers to implementation, and provide insight into the new service. In addition to expanding the tool into nonpsychiatric areas, a morphine-equivalents calculator was developed to identify patients receiving at least 100 mg of morphine equivalents per day to capture an additional at-risk population. Four short educational videos were developed to provide training to pharmacists. Initial performance of the screening tool was evaluated in general medicine patients over a 5-day period. Out of 44 admissions, 8 (18.2%) screened positive. The majority of those patients (5\/8, 62.5%) screened positive for morphine equivalents greater than 100 mg. Anecdotally, the educational videos have been well received by pharmacy staff. Opioid overdose risk factors can be applied to nonpsychiatric inpatients for screening purposes in the EMR. Educational videos can be used to disseminate information to pharmacists on take-home naloxone and opioid overdose.<\/jats:p>","DOI":"10.9740\/mhc.2019.03.105","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T21:49:33Z","timestamp":1551476973000},"page":"105-109","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation and optimization of take-home naloxone in an academic medical center"],"prefix":"10.9740","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-6139","authenticated-orcid":false,"given":"Jordan","family":"Cooler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-782X","authenticated-orcid":false,"given":"Clint A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Psychiatry, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-0252","authenticated-orcid":false,"given":"Sophie","family":"Robert","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Psychiatry, Research Assistant Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4587-7669","authenticated-orcid":false,"given":"Lauren","family":"Linder","sequence":"additional","affiliation":[{"name":"Clinical Pharmacist, Medicine-Psychiatry, Palmetto Health-Richland Campus, Columbia, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-4546","authenticated-orcid":false,"given":"Ann Marie","family":"Ruhe","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist in Psychiatry, Sheppard Pratt Health System, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-8012","authenticated-orcid":false,"given":"Achsah","family":"Philip","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Analyst, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"author":"Centers for Disease Control and Prevention","key":"2022042505184237600_i2168-9709-9-2-105-b01","article-title":"Opioid overdose: data overview"},{"issue":"50-1","key":"2022042505184237600_i2168-9709-9-2-105-b02","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022042505184237600_i2168-9709-9-2-105-b03","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.10.013","article-title":"Legal changes to increase access to naloxone for opioid overdose reversal in the United States","volume":"157","author":"Davis","year":"2015","journal-title":"Drug Alcohol Depend"},{"journal-title":"DailyMed [Internet]. [2005]-[2018]","article-title":"Narcan (naloxone hydrochloride) nasal spray. 2015 [rev. 2017 Dec; cited 2018 May 28]","author":"Adapt Pharma Inc","key":"2022042505184237600_i2168-9709-9-2-105-b04"},{"author":"US Food and Drug Administration","key":"2022042505184237600_i2168-9709-9-2-105-b05","article-title":"FDA approves new hand-held auto-injector to reverse opioid overdose, April 2014 [cited 2018 Jun 15]"},{"author":"US Food and Drug Administration [Internet]","key":"2022042505184237600_i2168-9709-9-2-105-b06","article-title":"FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose, November 2015 [cited 2018 May 29]"},{"author":"HHS.gov [Internet]","key":"2022042505184237600_i2168-9709-9-2-105-b07","article-title":"Surgeon general release advisory on naloxone, an opioid overdose-reversing drug, April 2018 [cited 2018 Jun 15]"},{"author":"Surgeon General.gov [Internet]","key":"2022042505184237600_i2168-9709-9-2-105-b08","article-title":"Surgeon general advisory on naloxone and opioid overdose, April 2018 [cited 2018 Jun 15]"},{"issue":"7","key":"2022042505184237600_i2168-9709-9-2-105-b09","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"author":"Scstatehouse.gov [Internet]","key":"2022042505184237600_i2168-9709-9-2-105-b10","article-title":"Code of Laws - Title 44 - Chapter 130 - South Carolina Overdose Prevention 2015 Act [cited 2018 Jun 28]"},{"journal-title":"College of Psychiatric and Neurologic Pharmacists [Internet]","article-title":"Naloxone access: a practical guide for pharmacists, October 2017","author":"CPNP Substance Abuse Task Force","key":"2022042505184237600_i2168-9709-9-2-105-b11"},{"issue":"13","key":"2022042505184237600_i2168-9709-9-2-105-b12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"2022042505184237600_i2168-9709-9-2-105-b13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1197\/j.aem.2007.04.005","article-title":"Identifying injection drug users at risk of nonfatal overdose","volume":"14","author":"Coffin","year":"2007","journal-title":"Acad Emerg Medicine"},{"issue":"3","key":"2022042505184237600_i2168-9709-9-2-105-b14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamainternmed.2014.6294","article-title":"Out-of-hospital mortality among patients receiving methadone for noncancer pain","volume":"175","author":"Ray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2022042505184237600_i2168-9709-9-2-105-b15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2014.09.001","article-title":"Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study","volume":"144","author":"Darke","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2022042505184237600_i2168-9709-9-2-105-b16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1874473711104040292","article-title":"Drug-related death following release from prison: a brief review of the literature with recommendations for practice","volume":"4","author":"Leach","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"issue":"3","key":"2022042505184237600_i2168-9709-9-2-105-b17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0376-8716(98)00097-0","article-title":"One-year mortality rates following methadone treatment discharge","volume":"52","author":"Zanis","year":"1998","journal-title":"Drug Alcohol Depend"},{"journal-title":"Poster presented at: 2017 College of Psychiatric and Neurologic Pharmacists Annual Meeting, 2017; Phoenix, AZ","article-title":"Assessment of naloxone prescribing patterns upon hospital discharge in psychiatric patients at risk for opioid overdose","author":"Linder","key":"2022042505184237600_i2168-9709-9-2-105-b18"},{"issue":"5","key":"2022042505184237600_i2168-9709-9-2-105-b19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/1060028014523730","article-title":"Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings","volume":"48","author":"Bailey","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"18","key":"2022042505184237600_i2168-9709-9-2-105-b20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2146\/ajhp140157","article-title":"The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems","volume":"71","author":"Cobaugh","year":"2014","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"2022042505184237600_i2168-9709-9-2-105-b21","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1331\/JAPhA.2014.13101","article-title":"Pharmacists' role in addressing opioid abuse, addiction, and diversion","volume":"54","author":"American Pharmacists Association","year":"2014","journal-title":"J Am Pharm Assoc (2003)"},{"author":"Naloxone Rescue [Internet]","key":"2022042505184237600_i2168-9709-9-2-105-b22","article-title":"Recommendations for issuing naloxone rescue for the VA opioid overdose education and naloxone distribution (OEND) program, August 2016"},{"issue":"8","key":"2022042505184237600_i2168-9709-9-2-105-b23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in veterans' health administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Med"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/2\/105\/2427808\/mhc_2019_03_105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/2\/105\/2427808\/mhc_2019_03_105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:22:50Z","timestamp":1731687770000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/9\/2\/article-p105.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2019.03.105","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}